The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2137202
WO Application Number:
IL2008000360
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08719985.7
WO Publication Number:
WO2008111082
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Israel (IL)
Publications:
Dates
Filing date:
13/03/2008
Grant date:
21/06/2017
EP Publication Date:
30/12/2009
WO Publication Date:
18/09/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
11/09/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
21/06/2017
EP B1 Publication Date:
21/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/03/2028
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
21/06/2017
Name:
Can-Fite Biopharma Ltd.
Address:
10 Bareket Street P.O. Box 7537, PETACH TIKVA 49170, Israel (IL)
Domicile Holder
Name:
ir. H.A. Witmans c.s.
From:
20/09/2017
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Inventor
1
Name:
BRUZINSKI, Paul
Address:
Clifton Park, NY 12065, United States of America (US)